On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from Kenneth Steiner, on the adoption of a Board policy that the Chairperson of the Board be an independent director was not approved.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.08 USD | +1.45% | -0.32% | -18.86% |
01:37pm | ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial | MT |
Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.86% | 84.08B | |
+46.70% | 765B | |
-6.60% | 354B | |
+19.95% | 331B | |
+9.07% | 299B | |
+18.83% | 248B | |
-1.88% | 219B | |
+10.86% | 216B | |
+5.02% | 164B | |
-3.35% | 162B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company